Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1-Reference-Cited by-同舟云学术

Q-TWiST analysis of pembrolizumab combined with chemotherapy as first-line treatment of metastatic triple-negative breast cancer that expresses PD-L1

Published:2022-12 Issue: Volume:177 Page:45-52
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Huang Min,O'Shaughnessy Joyce,Haiderali Amin,Pan Wilbur^ORCID,Hu Peter,Chaudhuri Mitashri,Le Bailly De Tilleghem Celine,Cappoen Nicolas,Fasching Peter A.^ORCID

Funder

Merck Sharp and Dohme

Merck & Co Inc

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference34 articles.

1. Features of triple-negative breast cancer: analysis of 38,813 cases from the national cancer database;Plasilova;Medicine (Baltim),2016

2. Pattern of metastatic spread in triple-negative breast cancer;Dent;Breast Cancer Res Treat,2009

3. Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design;Kassam;Clin Breast Cancer,2009

4. Triple-negative breast cancer: recent treatment advances;Bergin;F1000Res,2019

5. Pembrolizumab and atezolizumab in triple-negative breast cancer;Kwapisz;Cancer Immunol Immunother,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements in Immunotherapy for Breast Cancer: Mechanisms, Efficacy, and Future Directions;Cureus;2024-08-31

2. Unveiling Epigenetic Vulnerabilities in Triple-Negative Breast Cancer through 3D Organoid Drug Screening;Pharmaceuticals;2024-02-08

3. The Application of Pembrolizumab in the Treatment of Triple Negative Breast Cancer;Advances in Clinical Medicine;2024

4. Recent advances in targeted strategies for triple-negative breast cancer;Journal of Hematology & Oncology;2023-08-28